Atlas Trials

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients

Clinical trial NCT02204241 · COMPLETED

Trial details

NCT number
NCT02204241
Sponsor
European Myeloma Network B.V.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-06-01
Primary completion
2015-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.